Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 01, 2022

SELL
$6.16 - $12.07 $4.18 Million - $8.19 Million
-678,385 Closed
0 $0
Q3 2021

Nov 03, 2021

BUY
$9.7 - $14.34 $1.14 Million - $1.68 Million
117,295 Added 20.9%
678,385 $6.78 Million
Q2 2021

Jul 30, 2021

BUY
$13.43 - $19.16 $7.54 Million - $10.8 Million
561,090 New
561,090 $7.96 Million

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $654M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Kornitzer Capital Management Inc Portfolio

Follow Kornitzer Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.